Supriya Life soars another 20% a day after debut; up 71% over issue price
Supriya Lifescience has a niche product portfolio of 38 APIs with focus primarily on diverse therapeutic areas.29-12-2021
29-12-2021
Supriya Lifescience: What should you do post bumper listing?
Going forward, investors must track the sustainability of margins and progress on the China+1 strategy28-12-2021
Supriya Lifescience Ltd - 543434 - Listing of equity shares of Supriya Lifescience Ltd
Trading Members of the Exchange are hereby informed that effective from December 28, 2021, the equity shares of Supriya Lifescience Ltd ( Scrip Code: 543434) are listed and admitted to dealings on the Exchange in the list of ''B'' Group Securities. For further details please refer to the notice no 20211227-6 dated December 27, 2021.28-12-2021
Supriya Lifescience trading at 47% premium in grey market. Check out share allotment, listing date
The public issue of active pharmaceutical ingredients supplier Supriya Lifescience was subscribed 71.51 times, with retail investors bidding 56.01 times the portion reserved for them21-12-2021
Supriya Lifescience IPO subscribed 5.69 times on Day 2 of offer
The initial share sale of Supriya Lifescience Limited received 5.69 times subscription on the second day of offer on Friday. The initial public offer (IPO) received bids for 8,27,05,698 shares against 1,45,28,299 shares on offer, as per NSE data. The category for Retail Individual Investor (RIIs) was subscribed 25.38 times, while non-institutional investors received 2.90 times subscription, and Qualified Institutional Buyers (QIBs) 53 per cent. The initial public offer of Supriya Lifescience was fully subscribed within a few hours of opening for subscription on Thursday on the back of a strong response from retail investors. The initial public offer has a fresh issue of up to Rs 200 crore and an offer-for-sale of up to Rs 500 crore. Price range for the offer is at Rs 265-274 per share. On Wednesday, the company raised Rs 315 crore from anchor investors. The proceeds from the fresh issue will be used for funding capital expenditure requirements, debt repayment, and general corpor17-12-2021
Subscribe to Supriya Lifescience: Motilal Oswal
Motilal Oswal has come out with its report on Supriya Lifescience. The research firm has recommended to ''Subscribe'' the ipo in its research report as on December 15, 2021.17-12-2021
Supriya Lifescience IPO Subscribed 2.33 Times On First Day Of Issue
The IPO of Supriya Lifescience was subscribed 2.33 times on Thursday, the first day of its issue16-12-2021
Supriya Lifescience IPO opens today. GMP, other details in 10 points
Supriya Lifescience IPO GMP today is 275 that means grey market is expecting Supriya Lifescience share listing at around 549, believe market observers16-12-2021
Pre-IPO Analyst Meet for Supriya Lifescience
Pre-IPO Conference Call with Supriya Lifescience. Listen to the full transcript.15-12-2021